- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Feb 23, 2024
Product Development
Amgen sees rare diseases as ‘fourth pillar’ of growth, driven by pair of 2022 deals
The big biotech spotlights pipeline, outlines commercial steps critical for drugs from Horizon, ChemoCentryx takeouts to reach more patients
Items per page:
1 - 10 of 242